Ketoacidosis is a significant and often a life-threatening complication of 
diabetes mellitus seen mostly in type 1 diabetes mellitus as well as 
occasionally in type 2 diabetes mellitus. Diabetic ketoacidosis usually 
manifests with high blood glucose more than 250 mg/dL, but euglycemic diabetic 
ketoacidosis is defined as ketoacidosis associated with blood glucose level less 
than 250 mg/dL. Normal blood glucose in such patients results in significant 
delay in diagnosis and management of diabetic ketoacidosis, thus increasing 
mortality and morbidity. We present a case of euglycemic diabetic ketoacidosis 
secondary to canagliflozin in a type 2 diabetic patient.